Erwin Fluks

Erwin Fluks currently serves as Commercial Director Benelux at BioCryst Pharmaceuticals, Inc., beginning in March 2024. Prior to this role, Fluks was the Commercial Lead for Rare Disease Netherlands at CSL Vifor, where responsibilities included representing the rare disease business unit leadership and reporting to senior European management. Fluks has a substantial background in commercial roles, including positions as Field Product Manager and National Key Account Manager at Sobi, where management involved multiple branded pharmaceuticals and establishing operational business strategies. Earlier career experiences include Product Manager at Teva Pharmaceuticals, Marketing Strategy & Planning Manager at Warner Chilcott, and Key Account Manager at Procter & Gamble Pharmaceuticals. Fluks holds a Master of Science in Business Economy from Vrije Universiteit Amsterdam and a Bachelor of Arts in International Marketing from Amsterdam University of Applied Sciences.